Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lactobacillus rhamnosus, particularly the LGG® strain, secretes p40 and p75 proteins that activate EGFR signaling, promoting intestinal epithelial cell survival and barrier integrity. Its SpaCBA pili enable strong adhesion to the gut lining, contributing to its immune-modulating and pathogen-inhibiting effects.
Reported Benefits (Provisional)
Origin & History
*Lactobacillus rhamnosus* is a widely studied probiotic strain naturally found in the human gut. Known for its resilience to stomach acid and bile, it effectively supports gut health, enhances immune function, and promotes overall well-being. This beneficial bacterium is commonly used in supplements and functional foods to restore and maintain a healthy gut microbiota.
Research Narrative (Provisional)
Extensive research, including clinical trials and in vitro studies, supports *Lactobacillus rhamnosus*'s role in gut and immune health. Modern science highlights its therapeutic potential in promoting digestion, mental health, and systemic balance.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Lactic Acid: Contributes to a balanced gut pH, inhibiting pathogenic bacteria. - Exopolysaccharides: Strengthen the gut barrier and support immune tolerance. - Bioactive Metabolites: Influence gut-brain axis signaling, impacting mood and cognitive function. - Competitive Exclusion: Limits pathogen colonization by competing for adhesion sites and nutrients.
Reported Mechanism (Provisional)
Lactobacillus rhamnosus, particularly the LGG® strain, exerts its effects primarily through secreted p40 and p75 proteins, which stimulate Epidermal Growth Factor Receptor (EGFR) via heparin-binding EGF-like growth factor (HB-EGF). This activation triggers PI3K/Akt, MAPK, and JNK pathways, enhancing epithelial cell survival, inhibiting apoptosis, preserving intestinal barrier function, and upregulating mucus production. Additionally, its SpaCBA pili facilitate robust adhesion to intestinal mucosa and contribute to immune modulation by inhibiting pro-inflammatory cytokine production.
Clinical Narrative (Provisional)
Clinical research, including randomized controlled trials and meta-analyses involving diverse populations, consistently demonstrates the efficacy of Lactobacillus rhamnosus in various gastrointestinal conditions. Studies have shown its effectiveness in reducing the incidence and duration of acute infectious diarrhea, preventing antibiotic-associated diarrhea, and alleviating symptoms of irritable bowel syndrome. Furthermore, emerging evidence from human trials suggests beneficial effects on immune modulation, allergy prevention in infants, and a positive impact on the gut-brain axis, potentially influencing mood and anxiety. While specific sample sizes vary greatly across numerous studies, the collective body of evidence supports its widespread use as a probiotic for gut and immune health.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.